CEO: Karsten Lindved
www.upfront-dk.com
Business:
UPFRONT has demonstrated that Expanded Bed Adsorption (EBA) is an efficient and costeffective technology platform across several industrial sectors in the biologics market. The company has created a strong intellectual property position comprising granted patents and applications and an extensive technology and regulatory know-how portfolio relating to separation processes and related chemistry and equipment.
UPFRONT’S technology and business strategy have been validated though commercial agreements with DSM (Holland), Chr. Hansen A/S (Denmark), Dairy Farmers (Australia) and AVT Holdings Ltd (China/Australia). In a cross-licensing agreement the company has also licensed the EBA technology to GE Healthcare (formerly Pharmacia).
Contact:
Main office:
UpFront Chromatography A/S
Lersø Parkallé 42
DK-2100 Copenhagen
Denmark
Phone: +45 39 27 37 63
Fax: +45 39 27 31 11
sales@upfront-dk.com